Section H — Coach Light — Circadian Medicine and Light Therapy Translation
This section covers the Master's chapter on Circadian Medicine and Light Therapy Translation, Lessons 1 through 5: Circadian Medicine Clinical Practice, Light Therapy Clinical Research Beyond SAD, Vitamin D Clinical Translation, Shift Work as Occupational Health Crisis, and Modern Indoor Light Environment as Population Intervention Target. All material is already in the chapter — no new content.
Part A — Vocabulary (20 points, 2 points each)
Select the single best answer for each question.
1. Lam et al. 2016 JAMA Psychiatry (foundational anchor) demonstrated:
A) Light therapy for SAD only B) Bright light treatment (10,000 lux, 30 min/day for 8 weeks) and fluoxetine and the combination produced antidepressant response in patients with non-seasonal major depressive disorder in a 4-arm RCT (n=122); paradigm-shifting for light therapy as treatment modality beyond seasonal indication; foundational anchor positioning light therapy WITHIN established depression treatment landscape per methodological-evidence-threshold framework C) Vitamin D efficacy D) Has been superseded
2. DLMO is:
A) A medication B) Dim-light melatonin onset — the timing of endogenous melatonin secretion onset measured in dim-light conditions; principal clinical biomarker of circadian phase for circadian rhythm sleep-wake disorders assessment (DSWPD, ASWPD, ISWRD, N24SWD); foundational chronotherapy reference point C) An imaging modality D) Has been superseded
3. AASM circadian classification includes:
A) Only DSWPD B) Delayed sleep-wake phase disorder (DSWPD), advanced sleep-wake phase disorder (ASWPD), irregular sleep-wake rhythm disorder (ISWRD), non-24-hour sleep-wake rhythm disorder (N24SWD), shift work disorder, jet lag disorder; AASM ICSD-3-TR framework C) Only jet lag D) Has been superseded
4. Khalsa 2003 phase-response curve (PRC) for bright light:
A) Animal study only B) Established human PRC for bright light — light pulses produce phase delays in evening (before core body temperature minimum) and phase advances in early morning (after CBTmin); foundational for clinical chronotherapy timing decisions for CRSWD treatment, jet lag, and shift work C) Has been superseded D) Applies only to SAD
5. Burgess 2010 melatonin dose-response study:
A) Was a behavioral study B) Established dose-response of low-dose melatonin (0.5 mg versus higher doses) for circadian phase shifting — supports lower-dose melatonin clinical translation than the over-the-counter doses (often 3-10 mg) commonly marketed; foundational chronotherapy melatonin dosing reference C) Has been superseded D) Was unrelated to phase shifting
6. VITAL trial (Manson 2019 NEJM) on vitamin D:
A) Confirmed broad supplementation benefit B) RCT in 25,871 general-population adults randomized 2x2 factorial to vitamin D3 2000 IU/day or placebo and marine omega-3 1g/day or placebo; primary endpoints (invasive cancer, major cardiovascular events) NULL in general population not selected for deficiency; substudy null findings across falls/fractures/depression/AMD/cognition/bone density; VITAL-RA Hahn 2022 BMJ exception in autoimmune disease incidence C) Has been superseded D) Confirmed universal supplementation benefit
7. IARC 2007/2019 shift work Group 2A classification:
A) Is unrelated to circadian B) International Agency for Research on Cancer classification of shift work involving circadian disruption as Group 2A "probably carcinogenic to humans" — based on epidemiologic cohort evidence including Schernhammer 2001 JNCI Nurses' Health Study breast cancer association; the methodologic literature (including Travis 2016 Million Women Study null finding) is complex; the policy framing is at structural occupational health level C) Has been superseded D) Applies only to certain shift patterns
8. Scheer 2009 PNAS forced desynchrony study:
A) Was a CWI study B) Demonstrated metabolic dysfunction (insulin resistance, dyslipidemia) from forced circadian desynchrony in laboratory conditions independent of sleep duration; foundational mechanism paper for shift work metabolic consequences beyond sleep deprivation alone C) Has been superseded D) Was unrelated to circadian
9. EU Working Time Directive (cross-reference Hot Master's L2):
A) Is unrelated to circadian B) The EU 2003/88/EC Working Time Directive provides structural worker-hour protections (48-hour weekly maximum, minimum rest periods, night-work limits) that contrast with the U.S. lack of federal worker-hour standard outside specific industries; the Light L4 shift work circadian-disruption policy gap parallels the Hot L2 OSHA heat exposure gap — occupational health policy gaps between U.S. and EU at Master's policy-comparison depth C) Has been resolved D) Applies only to manufacturing
10. USPSTF 2021 vitamin D recommendation:
A) Endorsed universal screening B) U.S. Preventive Services Task Force 2021 recommendation against routine vitamin D deficiency screening in asymptomatic adults — Grade I "insufficient evidence" / Grade D against — reflecting VITAL trial findings and the broader vitamin D supplementation literature C) Has been superseded D) Endorsed universal supplementation
Part B — Concept Comprehension (20 points, 2 points each)
Select the single best answer for each question.
11. Chronotherapy clinical practice at Master's depth:
A) Has no clinical translation B) Includes light therapy at appropriate circadian phase (informed by DLMO and PRC), melatonin at appropriate phase (Burgess 2010 dose framework), sleep scheduling adjustments, and chronopharmacology (chemotherapy timing, BP medication timing per MAPEC/Hygia contrasted with TIME 2022 null); foundational clinical translational application of circadian biology C) Has been resolved D) Applies only to research
12. Light therapy beyond SAD at Master's depth:
A) Has no evidence beyond SAD B) Lam 2016 JAMA Psychiatry in non-seasonal MDD (foundational anchor); light therapy research in eating disorders, ADHD, dementia sundowning; dawn simulation literature; wavelength-and-timing specificity; the methodological-evidence-threshold framework positions light therapy WITHIN established depression treatment landscape C) Has been superseded D) Applies only to seasonal indication
13. Vitamin D threshold debate:
A) Has been resolved B) IOM 2011 (20 ng/mL threshold) versus Endocrine Society 2011 (30 ng/mL threshold) framework debate; subsequent VITAL trial null primary endpoints in general population reframed the supplementation conversation; clinical decisions individualized to deficiency status, latitude, skin pigmentation, age, medical history C) Has been superseded D) Has been universally agreed
14. Shift work and breast cancer epidemiology at Master's depth:
A) Has been resolved B) Schernhammer 2001 JNCI Nurses' Health Study established initial breast cancer association with rotating night shift work in nurses; subsequent cohort literature including Travis 2016 JNCI Million Women Study found null association in pooled prospective cohorts; complex methodologic literature underlies the IARC 2019 maintained Group 2A classification C) Has been definitively rejected D) Has been universally validated
15. Roenneberg social jet lag epidemiology:
A) Has no population dimension B) Measures discrepancy between sleep timing on work-free versus workday using MCTQ — population-scale documentation of chronic mild circadian misalignment in modern industrial societies; metabolic and cardiovascular epidemiologic correlations; informs the modern indoor light environment public health framework C) Has been resolved D) Applies only to shift workers
16. Wright 2013 Current Biology camping studies:
A) Were laboratory studies B) Real-world camping studies in adults showing rapid SCN entrainment to natural light-dark cycle (~2 days) and partial entrainment in shorter camping trips; foundational research on the relative weakness of modern indoor light versus natural outdoor light for circadian entrainment; supports the modern indoor light environment as population intervention target framework C) Were drug trials D) Has been superseded
17. mEDI (melanopic equivalent daytime illuminance) and CIE S 026/E:2018*:
A) Is unrelated to circadian B) The standardized framework for quantifying biologically-relevant light exposure based on melanopsin spectral sensitivity (the ipRGC pathway driving circadian entrainment); CIE S 026/E:2018 metric replaces older photopic-illuminance-based metrics for circadian-relevant light measurement; foundational standardization for circadian lighting research and policy C) Has been superseded D) Applies only to research
18. WELL Building Standard circadian lighting provisions:
A) Has no circadian application B) The WELL Building Standard certification framework includes circadian lighting provisions (mEDI-based daytime illuminance thresholds, evening light reduction guidance) integrating circadian science into building design; one example of circadian biology translation into built-environment policy; one component of the broader modern indoor light environment intervention framework C) Has been resolved D) Applies only to research
19. Wellness-industry circadian lighting overclaim at Master's depth:
A) Has no concern B) Operates at the wellness-industry-research-gap pattern — circadian lighting consumer products often make claims (sleep optimization, productivity enhancement, mood improvement) exceeding intervention research support; the five-point framework (design, population, measurement, effect size, replication) applied at Master's depth distinguishes well-supported circadian biology from product marketing claims C) Has been resolved D) Has been validated
20. Coach Light integrator position at Master's depth (Synchronizer):
A) Is abstract B) The Synchronizer position at Master's translational depth holds circadian medicine clinical practice (Light L1), light therapy clinical research beyond SAD with Lam 2016 anchor (Light L2), vitamin D clinical translation with VITAL framework (Light L3), shift work as occupational health crisis with IARC Group 2A and EU Working Time Directive (Light L4), and modern indoor light environment as population intervention target with mEDI/WELL/wellness-industry-overclaim framework (Light L5) — external timing signal now framed through clinical translational, occupational, and built-environment public-health translational layers C) Same as Internal Environment D) Same as Consolidation
Part C — Application (30 points, 6 points each)
Write 5-7 complete sentences with specific reference to chapter content, primary literature citations, and methodological framings where asked.
21. Lam 2016 JAMA Psychiatry as foundational anchor and methodological-evidence-threshold framework. Walk the Lam et al. 2016 JAMA Psychiatry RCT design (4-arm trial in non-seasonal MDD, 122 patients, bright light treatment + fluoxetine + combination + double placebo over 8 weeks) and findings (active treatments produced antidepressant response; combination strongest). Articulate why this trial is the foundational anchor — paradigm-shifting for light therapy as treatment modality beyond seasonal indication. Position light therapy WITHIN established depression treatment landscape per the methodological-evidence-threshold framework, contrasted with breathwork (Balban 2023) and cold-and-mood (Buijze 2016) positioned OUTSIDE.
22. VITAL trial methodology and the vitamin D clinical translation framework. Walk the Manson et al. 2019 NEJM VITAL trial methodology (n=25,871 general-population adults, 2x2 factorial randomization to vitamin D3 2000 IU/day or placebo and marine omega-3 or placebo, median 5.3-year follow-up). State the primary endpoint findings (null for cancer and cardiovascular events). State the VITAL-RA Hahn 2022 BMJ exception (autoimmune disease incidence). Apply the IOM 2011 versus Endocrine Society 2011 threshold debate framework. Articulate the USPSTF 2021 recommendation against routine screening. What does VITAL demonstrate about general-population vitamin D supplementation versus targeted supplementation in identified deficiency?
23. Shift work and circadian medicine cross-coach integration with Sleep Master's L1-L2. Walk the circadian medicine clinical practice framework — AASM circadian classification (DSWPD, ASWPD, ISWRD, N24SWD, shift work disorder, jet lag disorder), DLMO measurement and actigraphy, chronotherapy via Khalsa 2003 PRC and Burgess 2010 melatonin dose-response. Cross-reference Sleep Master's Lessons 1-2 (clinical sleep medicine and circadian translational medicine). Walk the shift work cancer epidemiology — Schernhammer 2001 JNCI Nurses' Health Study with subsequent cohort literature including Travis 2016 Million Women Study null finding; IARC 2007/2019 Group 2A classification; EU Working Time Directive contrast with U.S. policy gap. How do Light L1/L4 and Sleep L1-L2 together build the circadian-medicine clinical translational framework?
24. Modern indoor light environment as population intervention target. Walk the modern indoor light environment framework at Master's depth — Wright 2013 Current Biology camping studies demonstrating SCN entrainment to natural light-dark cycle, Roenneberg social jet lag epidemiology, indoor light intensity building physics, mEDI CIE S 026/E:2018 framework, WELL Building Standard circadian lighting provisions. Apply the wellness-industry circadian lighting overclaim five-point framework (design, population, measurement, effect size, replication). How does the chapter position circadian lighting as a population-scale built-environment intervention target without endorsing consumer-product overclaim?
25. Eye safety and morning outdoor light exposure clinical framing. Walk the eye safety central principle — never direct sun-gazing (retinal damage risk); the wellness-industry "view the sun" shorthand is reframed as "morning outdoor light exposure with appropriate eye care." Outdoor activity (walking, sitting in natural light, exercise outdoors) provides circadian entrainment benefit without eye safety risk. For persistent low mood with seasonal onset: route to clinical evaluation for SAD assessment; clinical management belongs in mental-health-clinician hands; bright light therapy (10,000 lux, 30 min morning, light box specifications) is established intervention within clinical context. Name verified currently-active crisis resources for distressing depressive symptoms: 988 (call or text 988), Crisis Text Line (text HOME to 741741), SAMHSA National Helpline (1-800-662-4357), National Alliance for Eating Disorders (866-662-1235). Identify the older NEDA helpline (1-800-931-2237) as non-functional.
Continue to Section I — Coach Water.